Share：
Share this content in WeChat
X
[Chinese][PDF]87094
• Review •
Application and research progress of MRI texture analysis in the diagnosis and treatment of prostate cancer
YU Na  WU Hui  NIU Guangming 

Cite this article as: Yu N, Wu H, Niu GM. Application and research progress of MRI texture analysis in the diagnosis and treatment of prostate cancer. Chin J Magn Reson Imaging, 2019, 10(12): 951-954. DOI:10.12015/issn.1674-8034.2019.12.018.


[Abstract] With big data and deep learning, image grouping represented by texture analysis has developed rapidly. It plays an active role in the early diagnosis, accurate treatment and prediction of recurrence of prostate cancer, and caters to the personalized diagnosis and treatment in the new era. The author reviews the research progress in the above aspects in order to provide new ideas for the imaging research of prostate cancer in China and evidence-based support for accurate medical treatment.
[Keywords] prostatic neoplasms；texture analysis；magnetic resonance imaging

YU Na Department of Imaging Diagnosis, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China

WU Hui Department of Imaging Diagnosis, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China

NIU Guangming * Department of Imaging Diagnosis, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China

*Corresponding to: Niu GM, E-mail: Cjr.niuguangming@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of Inner Mongolia Natural Science Foundation Project No.2017MS (LH)0837
Received  2019-05-10
DOI: 10.12015/issn.1674-8034.2019.12.018
Cite this article as: Yu N, Wu H, Niu GM. Application and research progress of MRI texture analysis in the diagnosis and treatment of prostate cancer. Chin J Magn Reson Imaging, 2019, 10(12): 951-954. DOI:10.12015/issn.1674-8034.2019.12.018.

[1]
Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol, 2017, 71(4): 618-629.
[2]
Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urology, 2007, 177(6): 2106-2131.
[3]
Fernandes ET, Sundaram CP, Long R, et al. Biopsy gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?. Bju Inter, 2015, 79(4): 615-617.
[4]
Kvle R, Mller B, Wahlqvist R, et al. Concordance between gleason scores of needle biopsies and radical prostatectomy specimens: A population-based study. Bju Inter, 2010, 103(12): 1647-1654.
[5]
Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/Ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA, 2015, 313(4): 390-397.
[6]
Aihara M, Wheeler TM, Ohori M, et al. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology, 1994, 43(1): 60-66.
[7]
El-Shater Bosaily A, Valerio M, Hu Y, et al. The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial. Prostate Cancer Prostatic Dis, 2016, 19(3): 258-263.
[8]
Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48(4): 441-446.
[9]
Rahmim A, Schmidtlein CR, Jackson A, et al. A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. Phys Med Biol, 2016, 61(1): 227-242.
[10]
许岗，赵文露，李梦娟，等. MR-T2WI纹理分析在前列腺癌诊断中初步应用．医学影像学杂志, 2019, 29(3): 458-462.
[11]
Sidhu HS, Benigno S, Ganeshan B, et al. Textural analysis of multiparametric MRI detects transition zoneprostate cancer. Eur Radiol, 2017, 27(6): 2348-2358．
[12]
Daniel M, Kuess P, Andrzejewski P, et al. Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer. Strahlenther Onkol, 2019, 195(5): 402-411.
[13]
Andrzejewski P, Kuess P, Knäusl B, et al. Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy. Radiother Oncol, 2015, 117(3): 509-514.
[14]
Thomas L, Kantz S, Hung A, et al. 68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost. Eur J Nucl Med Mol Imaging, 2018, 45(7): 1-9.
[15]
Perera M, Krishnananthan N, Lindner U, et al. An update on focal therapy for prostate cancer. Nat Rev Urol, 2016, 13(11): 641-653.
[16]
Bates A, Miles K, 黄黎香. MR纹理分析检测移行带前列腺癌的前列腺特异性膜抗原PET/MRI验证．国际医学放射学杂志, 2018, 41(1): 124.
[17]
Kesch C, Radtke JP, Wintsche A, et al. Correlation between genomic index lesions and mpMRI and Ga-PSMA-PET/CT imaging features in primary prostate cancer. Sci Rep, 2018, 8(1): 16708.
[18]
Niu XK, Chen ZF, Chen L, et al. Clinical application of biparametric MRI texture analysis for detection and evaluation of high-grade prostate cancer in zone-specific regions. AJR Am J Roentgenol, 2018, 210(3): 549-556.
[19]
Chen T, Li M, Gu YF, et al. Prostate cancer differentiation and aggressiveness: Assessment with a radiomic-based model vs. PI-RADS v2. J Magn Reson Imaging, 2019, 49(3): 875-884.
[20]
Rozenberg R, Thornhill RE, Flood TA, et al. Whole tumor quantitative apparent diffusion coefficient histogram and texture analysis to predict gleason score upgrading in intermediate-risk 3+4=7 prostate cancer. AJR Am J Roentgenol, 2016, 206(4): 775-782.
[21]
Shiradkar R, Ghose S, Jambor I, et al. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings. J Magn Reson Imaging, 2018, 48(6): 1626-1636.
[22]
Gnep K, Fargeas A, Ricardo E, et al. Haralick textural features on T2- weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging, 2017, 45(1): 103-117.
[23]
Hamid A, Kiarash T, Bahram M, et al. MRI radiomic analysis of IMRT- induced bladder wall changes in prostate cancer patients: A relationship with radiation dose and toxicity. J Med Imaging Radiat Sci, 2019, 50(2): 252-260.
[24]
Scalco E, Rancati T, Pirovano I, et al. Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer. Med Phys, 2018, 45(4): 1518-1528.
[25]
Cohen JG, Goo JM, Yoo RE, et al. Software performance in segmenting ground-glass and solid components of subsolid nodules in pulmonary adenocarcinomas. Eur Radiol, 2016, 26(12): 4465-4474.
[26]
Limkin EJ, Sun R, Dercle L, et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol, 2017, 28(6): 1191-1206.

PREV Advances in magnetic resonance imaging in the diagnosis of prostate cancer
NEXT Research progress and clinical application of three-dimensional magnetic resonance arterial spin labeling
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn